Laboratorios Farma | ROVI - Operating Profit

Stock Price
58.95
Daily Change
-0.45 -0.76%
Monthly
-30.73%
Yearly
13.47%
Q2 Forecast
57.41

Laboratorios Farma reported EUR135.05M in Operating Profit for its fiscal semester ending in December of 2023.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Almirall EUR 30.23M 12.8M Dec/2025
Avita Medical AUD -10.41M 742K Dec/2025
Dianthus Therapeutics USD -69.54M 29.25M Dec/2025
Ionis Pharmaceuticals USD -118M 97M Mar/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Moderna USD -1.39B 531M Mar/2026
Organon & Co USD 217M 171M Dec/2025
Pharma Mar EUR 622K 42.99M Mar/2026
Revvity USD 82.77M 63.06M Mar/2026
Tectonic Therapeutic USD -21.52M 374K Dec/2025
Viatris USD -20.2M 137.3M Mar/2026
Xeris Pharmaceuticals USD 16.77M 10.04M Dec/2025